CNTB - Connect Biopharma Holdings Ltd

QQQ na $ -6.70 (-1.26 %)

DIA na $ -7.49 (-1.74 %)

SPY na $ -6.31 (-1.05 %)

TLT na $ -1.01 (-1.16 %)

GLD na $ 4.23 (1.35 %)

Previous Close

$ 0.95

Open

$ 0.95

Bid

-- x --

Ask

-- x --

Day's Range

$ 0.95 - $ 0.95

52 Week Range

$ 0.51 - $ 1.79

Volume

457,759

Average Volume

Market Cap

52.58M

Beta (5Y Monthly)

$ 0.76

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	05-15-2025	03-31-2025	10-Q
2	03-31-2025	12-31-2024	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Connect Biopharma Presents Clinical Data S...
06/13/2025 13:07:30

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma –– Ra...

HC Wainwright & Co. Assumes Connect Biopha...
06/12/2025 10:59:36

HC Wainwright & Co. analyst Brandon Folkes assumes Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy rating and announces...

Connect Biopharma Files For Mixed Shelf Of...
06/10/2025 20:38:51

-SEC Filing

Connect Biopharma Announces Reduction in A...
06/03/2025 13:06:21

Connect Biopharma Presents Clinical And Pr...
05/20/2025 13:05:47

– Rademikibart significantly improved airway function, as measured by FEV1, within a day and significantly reduced acute exacer...

Connect Biopharma Hldgs Q1 EPS $(0.19) Dow...
05/15/2025 13:05:44

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.19) per share. This is a 18.75 percent decrease over los...

Connect Biopharma Initiates Phase 2 Seabre...
05/14/2025 13:05:28

– Expect to report topline data from the Seabreeze STAT COPD study in 1H 2026 –SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Conn...

Connect Biopharma Initiates Phase 2 Seabre...
05/13/2025 13:01:53

– Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 –– On track to initiate similarly-designed Phas...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
04/07/2025 12:08:52

HC Wainwright & Co. Reiterates Buy on Conn...
04/01/2025 16:37:12

HC Wainwright & Co. analyst Emily Bodnar reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $8 pr...

Connect Biopharma Reports Data From Global...
03/31/2025 20:09:22

HC Wainwright & Co. Reiterates Buy on Conn...
03/31/2025 16:37:41

HC Wainwright & Co. analyst Emily Bodnar reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $8 pr...

Connect Biopharma FY24 EPS $(0.28) Up From...
03/31/2025 13:05:53

Connect Biopharma Receives Nasdaq Deficien...
03/28/2025 20:07:42

HC Wainwright & Co. Reiterates Buy on Conn...
09/06/2024 11:33:21

HC Wainwright & Co. analyst Emily Bodnar reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $8 pr...

Connect Biopharma Hldgs H1 EPS $0.14 Up Fr...
09/05/2024 20:35:12

Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly earnings of $0.14 per share. This is a 125.45 percent increase over lo...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
06/13/2024 12:07:12

HC Wainwright & Co. Reiterates Buy on Conn...
06/13/2024 10:36:57

HC Wainwright & Co. analyst Emily Bodnar reiterates Connect Biopharma Hldgs (NASDAQ:CNTB) with a Buy and maintains $8 pr...

Connect Biopharma Appoints Barry Quart As ...
06/12/2024 20:17:43

Xanthopoulos succeeds Wubin (Bill) Pan, who will remain on the Board and serve as an advisor to the Company during the transiti...

Connect Biopharma Presents Abstract About ...
05/22/2024 20:14:39

Rademikibart treatment significantly improved lung function at Week 12; improvements were observed as early as Week 1 and susta...